Cargando…
2nd Gordon Hamilton Fairley Lecture*: Need for new approaches to the treatment of patients in clinical remission, with special reference to acute myeloid leukaemia
A serious limitation of chemotherapy for acute myeloid leukaemia (AML), Hodgkins disease and some classes of breast cancer is that, even when clinically evident disease responds well, the same chemotherapy when given during remission does not affect the rate of relapse after chemotherapeutic or surg...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1982
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011078/ https://www.ncbi.nlm.nih.gov/pubmed/6960922 |